NeonatalHypoglycemiaFailures

When a baby is born, it transitions abruptly from a continuous glucose supply through the placenta to an intermittent supply through feeding. Most infants handle this transition without difficulty — glucose falls in the first hour or two and then stabilizes. However, a meaningful fraction of newborns have risk factors that compromise that transition, and in those infants, glucose can fall low enough and stay low long enough to cause harm.

There is no single threshold that defines neonatal hypoglycemia across all contexts. The American Academy of Pediatrics and the Pediatric Endocrine Society use plasma glucose thresholds in the 40 to 45 mg/dL range as operational triggers for intervention in the first 48 hours, with different thresholds in symptomatic versus asymptomatic infants and in the first hours versus later. What matters clinically is the duration and depth of hypoglycemia, not any single number — and that is why protocol-based serial screening matters more than any single test.

Severe or prolonged hypoglycemia injures the brain in a specific pattern. MRI in the days and weeks following the event typically shows abnormal signal in the parietal and occipital lobes — the back of the brain — producing a constellation of findings that can include cortical visual impairment, seizure disorders, motor delays, and significant cognitive impairment. In the most severe cases, the imaging and clinical pattern overlaps with cerebral palsy.

The American Academy of Pediatrics has published a specific protocol for screening asymptomatic at-risk newborns, and most Florida hospitals have order sets that implement it. The recognized high-risk groups include:

• Infants of diabetic mothers. Whether gestational or pre-existing diabetes, these infants often have high circulating insulin levels that sharply drop glucose in the first hours after birth.
• Large-for-gestational-age infants. Birth weight above the 90th percentile — often in the setting of maternal diabetes or glucose intolerance — is an independent risk factor.
• Small-for-gestational-age infants. Birth weight below the 10th percentile, reflecting inadequate glycogen stores. These infants often cannot sustain glucose long enough between feedings.
• Late preterm infants. 35 to 37 weeks of gestation. Term enough to go to the regular nursery, but not yet mature enough to regulate glucose reliably.
• Perinatal stress. Infants who experienced meconium aspiration, birth asphyxia, or hypoxic ischemic encephalopathy — and infants who underwent therapeutic hypothermia.
• Symptomatic infants. Any infant — regardless of risk-factor status — who shows jitteriness, poor feeding, lethargy, hypotonia, temperature instability, or seizures should be checked for hypoglycemia as part of the workup.

Every one of these categories has established screening guidance. Hospitals that implement the guidance catch hypoglycemia early and treat it before injury occurs. The cases that produce permanent damage are almost always the cases where the high-risk label was missed, the order set was not activated, or the screening was done on paper but not on the protocol.

The American Academy of Pediatrics clinical practice guidelines specify timing, thresholds, and escalation steps. Typical components of a screening protocol include:

• First check within 30 to 60 minutes of birth for high-risk infants, even before the first feeding if indicated by risk category.
• Recheck before each feeding for the first several hours, with the frequency depending on the trajectory and category.
• Protocol-defined thresholds for intervention — feeding, dextrose gel, or IV dextrose — with different thresholds in the first 4 hours versus 4 to 24 hours versus beyond.
• Escalation when the first intervention fails. An infant whose glucose does not rise adequately after feeding, or who is symptomatic, requires IV dextrose — not repeat feeding attempts.
• Clear discharge criteria. No infant in a screening protocol should be discharged until glucose has been demonstrably stable on feedings alone, with documentation.

The standard of care is not perfection — infants occasionally have glucose trajectories that surprise a competent team. The standard of care is following the protocol, documenting each step, escalating when the data says to, and not discharging a high-risk infant who is still demonstrating instability.

Cases that produce permanent injury typically involve one or more of the following patterns in the records:

• Missed risk-factor identification. The chart does not note that the mother had gestational diabetes, that the infant was large-for-gestational-age, or that the infant was late preterm — and the screening protocol was never activated.
• Screening omitted. The infant was flagged as high-risk but the first glucose check came at 4 or 6 hours — not within the first hour.
• Low level unaddressed. A reading below threshold is in the chart, documented, and nothing happens. No feeding attempt, no recheck within the required interval, no escalation.
• Feeding-only management. An infant with a level well below the threshold is offered breast or bottle and re-checked 2 hours later — when the protocol called for IV dextrose.
• Symptomatic infant managed outside the ICU. An infant showing jitteriness, poor tone, or seizures is not transferred to a NICU for IV glucose — the signs are attributed to something else.
• Early discharge. An infant is sent home before the screening protocol is completed, before glucose is stable on ad-lib feedings, or before the family is capable of continuing close feeding.

Each of these patterns leaves a paper trail that can be reconstructed by qualified experts.

The central evidentiary strength of a neonatal hypoglycemia case is often the imaging. MRI obtained in the days or weeks following a severe hypoglycemic episode can show the characteristic parieto-occipital injury pattern — abnormal signal in the back of the brain — that a pediatric neuroradiologist can interpret as consistent with hypoglycemic injury. Paired with documented low glucose levels in the chart and a recognized high-risk context, causation can often be established with reasonable medical certainty.

Florida Statute § 766.102 requires a corroborating expert affidavit from a board-certified specialist in the same specialty as each defendant before suit is filed. Neonatologists testify to the standard of care for screening and management. Pediatric neurologists and neuroradiologists testify to the injury pattern and causation. These are specialty cases and should be pursued by firms that can assemble the right experts.

The pre-suit investigation period is 90 days during which the defense is given notice of the claim and an opportunity to respond. The statute of limitations is tolled during this period. Once pre-suit closes, suit is filed and discovery begins.

A severe neonatal hypoglycemia case produces a lifetime care need — often including seizure management, vision services for cortical visual impairment, developmental therapy, adaptive communication, and in some cases around-the-clock attendant care. A certified life-care planner and an economist project the full cost over the child's life expectancy, discounted to present value.

Florida recoverable categories include all past and future medical expenses, the complete life-care plan, lost earning capacity for a child whose impairments limit their vocational options, non-economic damages for pain and suffering and loss of enjoyment of life (uncapped after North Broward Hospital District v. Kalitan, 219 So. 3d 49 (Fla. 2017)), and loss of consortium. These cases are actively defended. No family should settle one without experienced trial counsel and a full life-care plan.